INTERNATIONAL SYMPOSIUM OF CARDIOVASCULAR IMAGING
DIC 2021
An Imaging Tour Around The World
Patrocinadores
Escolha sua sala e aproveite o conteúdo
SALA 1
SALA 2
Programação
SALA 1
09:00 – SESSION 1 – New Developments in the evaluation of ventricular function
Old Stuff – M Mode, Tei index, MAPSE and S wave – does it adds anything to the clinical picture?
Speaker: Ricardo Ronderos
LVEF with or without myocardial oppacification. What should I do?
Speaker: Thomas Porter
LV Longitudinal Strain: clinical value in different scenarios.
Speaker: Victoria Delgado
RV and LV Longitudinal Strain: technical pitfalls and clinical value.
Speaker: Denisa Muraru
LA Longitudinal Strain: technical pitfalls and clinical value.
Speaker: Matteo Cameli
Thansthoracic 3D echo: What is it’s additional value over traditional methods for the evaluation of LV Function?
Speaker: Luigi Badano
Echo In SARS CoV2: What shall we look for?
Speaker: Bijoy K. Khandheria
13:00 – SESSION 2 – Interventional Echocardiography
RASHKIND: Do we still need echo in order to perfom it?
Speaker: Victor Guerra
PFO and ASD: technical pitfalls for the begginer.
Speaker: Ricardo Pignatelli
TAVI: Technical pitfalls of minimalist aproach.
Speaker: Bernard Cosyns
Advantages of using TEE during TAVI
Speaker: Victoria Delgado
Valve in valve: What are the parameters and complications I should look for?
Speaker: Judd Hung
MITRA-FR and COAPT: lessons from winning and failing
Speaker: Federico Asch
Percutaneous tricuspid interventions: present and future.
Speaker: Rebecca Hahn
16:50 – SESSION 3 – Heart Valve Disease for Everyday Practice
Mitral Valve Prolapse or MV Billowing: What are the criteria and how should I properly and easily name it?
Speaker: Denisa Muraru
Mitral valve prolapse in the octagenarian: When to intervene?
Speaker: Maurice Sarano
Mitral regurgitation: to quantify of not quantify: That is the question.
Speaker: Maurice Sarano
Aortic Stenosis with normal flow: How to determine the best timing for intervention.
Speaker: Juan Carlo Plana
Low Flow Low Gradient Aortic Stenosis with Preserved LVEF: How to determine the best timing for intervention.
Speaker: Philippe Pibarot
Low Flow Low Gradient Aortic Stenosis with Depressed LVEF: How to determine the individuals at the highest risk.
Speaker: Vera Rigollin
Tricuspid regurgitation: Step by step aproaches for determination of mechanism, severity and impact on RV function and Cardiac output.
Speaker: Roberto Lang
SALA 2
09:00 – SESSION 1 – Challenging Imaging in 2021 in Late-Postoperative of Congenital Heart Disease
Transposition of great Arteries
Speaker: Vitor Guerra
Tetralogy of Fallot
Speaker: Laura M Mercer-Rosa
10:40 – SESSION 2 – Vascular Ultrasound Update
Update – ASE Recommendations for the Assessment of Carotid Arterial Plaque by US
Speaker: Amer M.Johri
Applicability of ASE Recommendations
Speaker: Joseph Polak
Update – Interpretation of Peripheral Arterial Doppler waveforms and clinical implication of new terminology
Speaker: Esther S.H.Kim
12:10 – SESSION 3 – Hot Topics in Nuclear Cardiology Around the World
How does Ischemia trial changes my practice?
Speaker: Randall C. Thompson
Best use of myocardial perfusion imaging in patients with suspect or known chronic coronary syndrome
Speaker: Robert C Hendel
Myocardial Flow Reserve with CZT – are we ready?
Speaker: Terence Ruddy
How is pyriphosphate scan amyloidosis is rewriting the epidemiology of a disease
Speaker: Sharmila Dorbala
PET in infectious e inflammatory diseases
Speaker: Panithaya Chareonthaitawee
14:10 – SESSION 4 – Hot topics in CMR around the world
Why CMR in Cardiac Amyloidosis?
Speaker: Marianna Fontana
CMR for valvopathies: What can it add to Echocardiogram?
Speaker: Bernard Guerber
CMR: What do arrhythmologists should know?
Speaker: Karen Ordovas
Positive troponin with normal coronary arteries: The role of CMR.
Speaker: Chiara Bucciarelli-Ducci
Why do we still need Myocardial Delayed Enhancement on the era of T1 Mapping?
Speaker: Han Kim
16:40 – SESSION 5 – Coronary Computed Tomography Dilemas Around The World
CCTA as the first test for patients with suspected CAD
Speaker: Armin Zadeh
Is asymptomatic patients screening the next step for CCTA?
Speaker: Michelle Williams
Where AI can help us on CCTA evaluation in 2021 (plaque analysis, FFR-CT and more)
Speaker: Pál Maurovich-Horvat
CT role in the follow up of percutaneous structural procedures
Speaker: João Cavaltante
Top 10 CCTA papers in 2020
Speaker: Todd Villines
19:10 – CLOSING SESSION
Coronary Physiology Assessment for the Diagnosis and Treatment of Coronary Artery Disease
Speaker: Marcelo Di Carli
Ultra-high resolution CT; the next frontier
Speaker: João A.C. Lima
